The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma

BACKGROUND: Transarterial chemoembolization (TACE) combined with sorafenib (TACE-S) or apatinib (TACE-A) is used in the treatment of hepatocellular carcinoma (HCC). However, to date, no study has compared the efficacy and safety of both treatments. The objective of this study was to compare the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Sun, Tao, Wu, Linxia, Zhang, Weihua, Ren, Yanqiao, Xiang, Dongqiao, Liang, Bin, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626166/
https://www.ncbi.nlm.nih.gov/pubmed/34840572
http://dx.doi.org/10.1155/2021/8169012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626166/
https://www.ncbi.nlm.nih.gov/pubmed/34840572
http://dx.doi.org/10.1155/2021/8169012

Ejemplares similares